SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-15-004152
Filing Date
2015-05-26
Accepted
2015-05-26 16:14:30
Documents
2
Period of Report
2015-05-21
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k052115_tianyinpharma.htm 8-K 30080
2 PRESS RELEASE f8k052115ex99i_tianyin.htm EX-99.1 13332
  Complete submission text file 0001213900-15-004152.txt   44863
Mailing Address 23RD FLOOR, UNIONSUN YANGKUO PLAZA NO.2, BLOCK 3, RENMIN ROAD SOUTH CHENGDU, P.R. F4 610041
Business Address 23RD FLOOR, UNIONSUN YANGKUO PLAZA NO.2, BLOCK 3, RENMIN ROAD SOUTH CHENGDU, P.R. F4 610041 0086-028-86154737
TIANYIN PHARMACEUTICAL CO., INC. (Filer) CIK: 0001362718 (see all company filings)

IRS No.: 204857782 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-34189 | Film No.: 15889583
SIC: 2834 Pharmaceutical Preparations